NATALIE KEYES: Open Payments
NPI 1285144584 · COLLINS, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$279 in 10 payments from 4 companies in 2025. Trend: 2023 $137 · 2024 $26 · 2025 $279
Food & beverage: $279
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $165 |
| Alkermes, Inc. | 4 | $79 |
| UCB, Inc. | 1 | $20 |
| Lundbeck LLC | 1 | $15 |
Products named: CAPLYTA, LYBALVI, Fintepla, REXULTI.
Industry payments across MS — which companies pay providers there.
